Skip to content

Gala Pharmaceutical Inc.: filings

Every Gala Pharmaceutical Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 33 filings, each linked to its SEC index.

Filing record ends 2019-07-23

The latest filing in this captured record is a 10-Q filed 2019-07-23. No later filing is in the SEC companyfacts record captured on 2026-09-22. Gala Pharmaceutical Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2019-07-23fiscal Q2 201928780001683168-19-002291
10-Q2019-04-30fiscal Q1 201929620001683168-19-001231
10-K2019-04-15fiscal FY 201832640001683168-19-001047
10-Q2018-10-26fiscal Q3 201830810001683168-18-003151
10-Q2018-08-01fiscal Q2 201829790001683168-18-002092
10-Q2018-05-08fiscal Q1 201822440001683168-18-001227
10-K2018-04-06fiscal FY 201729600001683168-18-000943
10-Q2017-10-19fiscal Q3 201725600001683168-17-002694
10-Q2017-07-28fiscal Q2 201717440001683168-17-001886
10-Q2017-04-18fiscal Q1 201716340001683168-17-000971
10-K/A2017-03-23fiscal FY 201622460001683168-17-000650
10-K2017-03-09fiscal FY 201622460001683168-17-000532
10-Q2016-11-04fiscal Q3 201618440001552781-16-002044
10-Q2016-07-15fiscal Q2 201617390001517126-16-000334
10-Q2016-05-10fiscal Q1 201618340001517126-16-000325
10-K2016-03-22fiscal FY 201521360001517126-16-000300
10-Q2015-10-20fiscal Q3 201517390001517126-15-000235
10-Q2015-07-30fiscal Q2 201516360001517126-15-000181
10-Q2015-04-22fiscal Q1 201517320001517126-15-000101
10-K2015-03-13fiscal FY 201418320001517126-15-000047
10-Q2014-10-20fiscal Q3 201416410001517126-14-000336
10-Q2014-07-18fiscal Q2 201418540001517126-14-000218
10-Q2014-04-28fiscal Q1 201418460001517126-14-000142
10-K2014-04-18fiscal FY 201319470001517126-14-000123
10-Q2013-10-29fiscal Q3 201317440001517126-13-000308
10-Q2013-07-19fiscal Q2 201321660001517126-13-000171
10-Q2013-04-15fiscal Q1 201321540001517126-13-000071
10-K2013-03-14fiscal FY 201219440001517126-13-000045
10-Q2012-10-15fiscal Q3 201218460001517126-12-000210
10-Q2012-07-18fiscal Q2 201217510001517126-12-000123
10-Q2012-04-23fiscal Q1 201214310001014897-12-000086
10-K2012-03-13fiscal FY 201116360001014897-12-000052
10-Q/A2011-11-09fiscal Q3 201114340001014897-11-000233

Inspect the source

Entity
Gala Pharmaceutical Inc. / CIK 0001513403
Captured
SEC response SHA-256
3d1db4681c9d9a4cd1ba58e701ccbc4c56e8be5f9d6000e0517ef1300b358a33

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001513403.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))